TY  - JOUR
AU  - Sánchez Barroso, Lara
AU  - Apellaniz Ruiz, Maria
AU  - Gutiérrez Gutiérrez, Gerardo
AU  - Santos, María
AU  - Roldán Romero, Juan M.
AU  - Curras, Maria
AU  - Remacha, Laura
AU  - Calsina, Bruna
AU  - Calvo, Isabel
AU  - Sereno, María
AU  - Merino, María
AU  - García Donas, Jesús
AU  - Castelo, Beatriz
AU  - Guerra, Eva
AU  - Letón, Rocio
AU  - Montero Conde, Cristina
AU  - Cascón, Alberto
AU  - Inglada Pérez, Lucía Silvia
AU  - Robledo, Mercedes
AU  - Rodríguez Antona, Cristina
PY  - 2018
DO  - 10.1634/theoncologist.2018-0418
SN  - 1083-7159
SN  - 1549-490X
UR  - https://hdl.handle.net/20.500.14352/94378
T2  - The Oncologist
AB  - Background. Peripheral neuropathy is the dose-limiting toxicity of many oncology drugs, including paclitaxel. There is large interindividual variability in the neuropathy, and several risk factors have been proposed; however, many have not been...
LA  - eng
M2  - 1
PB  - Oxford Academic
KW  - Paclitaxel
KW  - Peropheral neuropathy
KW  - Risk factors
KW  - Concomitant medications
KW  - Comorbidities
TI  - Concomitant Medications and Risk of Chemotherapy-Induced Peripheral Neuropathy
TY  - journal article
VL  - 23
ER  -